Literature DB >> 32470339

Trait-related changes in brain network topology in premenstrual dysphoric disorder.

Rotem Dan1, Inbal Reuveni2, Laura Canetti3, Marta Weinstock4, Ronen Segman2, Gadi Goelman5, Omer Bonne2.   

Abstract

The female predominance in the prevalence of depression is partially accounted by reactivity to hormonal fluctuations. Premenstrual dysphoric disorder (PMDD) is a reproductive subtype of depression characterized by cyclic emotional and somatic symptoms that recur before menstruation. Despite the growing understanding that most psychiatric disorders arise from dysfunctions in distributed brain circuits, the brain's functional connectome and its network properties of segregation and integration were not investigated in PMDD. To this end, we examined the brain's functional network organization in PMDD using graph theoretical analysis. 24 drug naïve women with PMDD and 27 controls without premenstrual symptoms underwent 2 resting-state fMRI scans, during the mid-follicular and late-luteal menstrual cycle phases. Functional connectivity MRI, graph theory metrics, and levels of sex hormones were computed during each menstrual phase. Altered network topology was found in PMDD across symptomatic and remitted stages in major graph metrics (characteristic path length, clustering coefficient, transitivity, local and global efficiency, centrality), indicating decreased functional network segregation and increased functional network integration. In addition, PMDD patients exhibited hypoconnectivity of the anterior temporal lobe and hyperconnectivity of the basal ganglia and thalamus, across menstrual phases. Furthermore, the relationship between difficulties in emotion regulation and PMDD was mediated by specific patterns of functional connectivity, including connections of the striatum, thalamus, and prefrontal cortex. The shifts in the functional connectome and its topology in PMDD may suggest trait vulnerability markers of the disorder.
Copyright © 2020 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Functional MRI; Functional connectivity; Graph theory; Menstrual cycle; PMDD; Premenstrual dysphoric disorder; Reproductive depression; Resting state; Sex hormones; fMRI

Mesh:

Year:  2020        PMID: 32470339     DOI: 10.1016/j.yhbeh.2020.104782

Source DB:  PubMed          Journal:  Horm Behav        ISSN: 0018-506X            Impact factor:   3.587


  5 in total

1.  Effects of an Oral Contraceptive on Dynamic Brain States and Network Modularity in a Serial Single-Subject Study.

Authors:  Kristian Høj Reveles Jensen; Drummond E-Wen McCulloch; Anders Stevnhoved Olsen; Silvia Elisabetta Portis Bruzzone; Søren Vinther Larsen; Patrick MacDonald Fisher; Vibe Gedsoe Frokjaer
Journal:  Front Neurosci       Date:  2022-06-14       Impact factor: 5.152

2.  Differential grey matter structure in women with premenstrual dysphoric disorder: evidence from brain morphometry and data-driven classification.

Authors:  Manon Dubol; Louise Stiernman; Johan Wikström; Rupert Lanzenberger; C Neill Epperson; Inger Sundström-Poromaa; Marie Bixo; Erika Comasco
Journal:  Transl Psychiatry       Date:  2022-06-15       Impact factor: 7.989

Review 3.  The Prominent Role of the Temporal Lobe in Premenstrual Syndrome and Premenstrual Dysphoric Disorder: Evidence From Multimodal Neuroimaging.

Authors:  Jingyi Long; Yuejie Wang; Lianzhong Liu; Juan Zhang
Journal:  Front Psychiatry       Date:  2022-06-28       Impact factor: 5.435

4.  Effects of exogenous melatonin on sleep and circadian rhythms in women with premenstrual dysphoric disorder.

Authors:  Christophe Moderie; Philippe Boudreau; Ari Shechter; Paul Lespérance; Diane B Boivin
Journal:  Sleep       Date:  2021-12-10       Impact factor: 6.313

5.  Traditional Chinese medicine on treating premenstrual syndrome and premenstrual dysphoric disorder: A protocol for systematic review and meta-analysis.

Authors:  Mingzhou Gao; Hui Sun; Wenjun Sun; Dongmei Gao; Mingqi Qiao
Journal:  Medicine (Baltimore)       Date:  2020-10-16       Impact factor: 1.817

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.